Abstract
Background: Primary membranous nephropathy is a rare presentation in children. Patients unresponsive to steroids and experiencing frequent relapse are considered steroid-resistant. They often require complex treatment regimens consisting of immunosuppressants like cyclophosphamide, tacrolimus, and cyclosporin A.
Case: In the present case, a 5-year-old child was suffering from steroid-resistant nephrotic syndrome for the past 10 months. He was initially treated with prednisolone 20mg but was subsequently found to be steroid-resistant. A renal biopsy revealed primary podocytopathy with immunocomplex deposits in podocyte tissues, suggesting primary membranous nephropathy as the cause of SRNS (steroid-resistant nephrotic syndrome). Cyclophosphamide 25mg twice daily was added to the treatment plan since the child did not tolerate tacrolimus therapy. During a subsequent follow-up, the physician reduced the cyclophosphamide 25mg dose to once a day, but parents misinterpreted this, and the child received a larger dose, cyclophosphamide 25mg, four times a day for 20 days. This resulted in cyclophosphamide toxicity-induced neutropenia, alopecia and posing the child at greater risk of sepsis.
Conclusion: Nephrotic syndrome is a chronic disease that demands extensive treatment plans and strict monitoring. Medication errors are common among parents or caregivers of pediatric patients. This case is a take-home message emphasizing the significance of patient-centered communication in preventing medication errors. A clinical pharmacist can aid in conveying simple and unambiguous information to parents or caregivers.
Keywords: Cyclophosphamide, medication error, overdose, patient education, prednisolone, steroid resistant nephrotic syndrome.
[http://dx.doi.org/10.1016/j.semnephrol.2009.03.015]
[http://dx.doi.org/10.1007/s40620-021-01108-9] [PMID: 34213762]
[http://dx.doi.org/10.1007/s00467-019-04225-7] [PMID: 30904930]
[http://dx.doi.org/10.1007/s00467-022-05639-6] [PMID: 35763086]
[http://dx.doi.org/10.1007/s13312-021-2217-3] [PMID: 33742610]
[http://dx.doi.org/10.1056/NEJMoa0810457] [PMID: 19571279]
[http://dx.doi.org/10.1046/j.1523-1755.2001.0590051919.x] [PMID: 11318964]
[http://dx.doi.org/10.1093/ndt/gfw344] [PMID: 28391342]
[http://dx.doi.org/10.1080/14740338.2021.1950138] [PMID: 34251951]
[http://dx.doi.org/10.1038/ki.1978.23] [PMID: 713276]
[http://dx.doi.org/10.1007/s00467-013-2574-9] [PMID: 23903693]
[http://dx.doi.org/10.1681/ASN.2016101121] [PMID: 28566477]
[http://dx.doi.org/10.1007/s13312-021-2262-y] [PMID: 33408286]
[http://dx.doi.org/10.1038/nrclinonc.2009.146] [PMID: 19786984]
[http://dx.doi.org/10.1007/BF01526181] [PMID: 9065658]
[http://dx.doi.org/10.1007/s00467-011-1841-x] [PMID: 21626223]
[http://dx.doi.org/10.1136/archdischild-2016-311877] [PMID: 28468867]
[http://dx.doi.org/10.4103/2249-4863.214433] [PMID: 29417022]
[http://dx.doi.org/10.1177/0009922810366734] [PMID: 20522613]
[http://dx.doi.org/10.1186/1471-2431-13-1] [PMID: 23281628]
[http://dx.doi.org/10.1016/j.jemermed.2020.04.027] [PMID: 32389431]
[http://dx.doi.org/10.1345/aph.1L549] [PMID: 19671803]
[http://dx.doi.org/10.1016/j.jemermed.2019.06.049] [PMID: 31591075]
[http://dx.doi.org/10.1097/PEC.0000000000001407] [PMID: 29406471]
[PMID: 23381705]
[http://dx.doi.org/10.1542/peds.2013-1454] [PMID: 24799542]
[PMID: 31000316]
[http://dx.doi.org/10.1213/XAA.0000000000001179] [PMID: 32224687]
[http://dx.doi.org/10.1097/PEC.0000000000000320] [PMID: 25469608]
[http://dx.doi.org/10.1016/j.arcped.2016.09.008] [PMID: 28492168]
[PMID: 30457732]
[http://dx.doi.org/10.2174/1574886315666201002124713] [PMID: 33006539]